<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8211617</journal-id>
<journal-id journal-id-type="pubmed-jr-id">6714</journal-id>
<journal-id journal-id-type="nlm-ta">Prog Neuropsychopharmacol Biol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Prog. Neuropsychopharmacol. Biol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Progress in neuro-psychopharmacology &amp; biological psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0278-5846</issn>
<issn pub-type="epub">1878-4216</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26545487</article-id>
<article-id pub-id-type="pmc">4728043</article-id>
<article-id pub-id-type="doi">10.1016/j.pnpbp.2015.11.001</article-id>
<article-id pub-id-type="manuscript">NIHMS738854</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Modeling mania in preclinical settings: a comprehensive review</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Sharma</surname>
<given-names>Ajaykumar N.</given-names>
</name>
<degrees>M.Pharm., Ph.D.</degrees>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="author-notes" rid="FN2">#</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fries</surname>
<given-names>Gabriel R.</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="author-notes" rid="FN2">#</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Galvez</surname>
<given-names>Juan F.</given-names>
</name>
<degrees>M.D.</degrees>
<xref ref-type="aff" rid="A3">c</xref>
<xref ref-type="author-notes" rid="FN2">#</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Valvassori</surname>
<given-names>Samira S.</given-names>
</name>
<degrees>Ph.D</degrees>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Soares</surname>
<given-names>Jair C.</given-names>
</name>
<degrees>M.D., Ph.D.</degrees>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Carvalho</surname>
<given-names>André F.</given-names>
</name>
<degrees>MD, Ph.D</degrees>
<xref ref-type="aff" rid="A5">e</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Quevedo</surname>
<given-names>Joao</given-names>
</name>
<degrees>M.D., Ph.D.</degrees>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>a</label>Center for Translational Psychiatry, Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, TX 77054, USA</aff>
<aff id="A2"><label>b</label>Center of Excellence on Mood Disorders, Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, TX 77054, USA</aff>
<aff id="A3"><label>c</label>Department of Psychiatry, Pontificia Universidad Javeriana School of Medicine, Bogotá, Colombia</aff>
<aff id="A4"><label>d</label>Laboratory of Neurosciences, Graduate Program in Health Sciences, Health Sciences Unit, University of Southern Santa Catarina, Criciúma, SC, Brazil</aff>
<aff id="A5"><label>e</label>Department of Clinical Medicine and Translational Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE, Brazil</aff>
<author-notes>
<corresp id="FN1">Address for correspondence: Dr. Joao L De Quevedo, M.D., Ph.D., Director and Professor, Center for Translational Psychiatry, Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, 1941 East Road. Suite 3140. Houston, TX 77054. USA. <email>Joao.L.DeQuevedo@uth.tmc.edu</email>, Phone: +1 (713) 486.2834, Fax: +1 (713) 486.2553</corresp>
<fn id="FN2">
<label>#</label>
<p>Shared first authorship.</p>
</fn>
<fn fn-type="conflict" id="FN3">
<p>
<bold>Conflicts of interest</bold>
</p>
<p>None.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>21</day>
<month>11</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="epub">
<day>04</day>
<month>11</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub">
<day>3</day>
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>03</day>
<month>4</month>
<year>2017</year>
</pub-date>
<volume>66</volume>
<fpage>22</fpage>
<lpage>34</lpage>
<!--elocation-id from pubmed: 10.1016/j.pnpbp.2015.11.001-->
<abstract>
<p id="P2">The current pathophysiological understanding of mechanisms leading to onset and progression of bipolar manic episodes remains limited. At the same time, available animal models for mania have limited face, construct, and predictive validities. Additionally, these models fail to encompass recent pathophysiological frameworks of bipolar disorder (BD), e.g. neuroprogression. Therefore, there is a need to search for novel preclinical models for mania that could comprehensively address these limitations. Herein we review the history, validity, and caveats of currently available animal models for mania. We also review new genetic models for mania, namely knockout mice for genes involved in neurotransmission, synapse formation, and intracellular signaling pathways. Furthermore, we review recent trends in preclinical models for mania that may aid in the comprehension of mechanisms underlying the neuroprogressive and recurring nature of BD. In conclusion, the validity of animal models for mania remains limited. Nevertheless, novel (e.g. genetic) animal models as well as adaptation of existing paradigms hold promise.</p>
</abstract>
<kwd-group>
<kwd>Mood disorders</kwd>
<kwd>Mania</kwd>
<kwd>Neuroprogression</kwd>
<kwd>Preclinical models</kwd>
<kwd>Animal models</kwd>
<kwd>Psychiatry</kwd>
<kwd>treatment-resistance</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>